Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
Kwang Dong Pharmaceutical Dividend Announcement
• Kwang Dong Pharmaceutical announced a annually dividend of ₩100.00 per ordinary share which will be made payable on 2024-04-25. Ex dividend date: 2023-12-27
• Kwang Dong Pharmaceutical annual dividend for 2023 was ₩100.00
• Kwang Dong Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.79%
• Kwang Dong Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 11.83%
• Kwang Dong Pharmaceutical's dividend growth over the last five years (2018-2023) was 4.56% year
• Kwang Dong Pharmaceutical's dividend growth over the last ten years (2013-2023) was 3.63% year
Kwang Dong Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-12-27 | ₩100.00 | annually | 2024-04-25 |
2022-12-28 | ₩100.00 | annually | 2023-04-20 |
2021-12-29 | ₩100.00 | annually | 2022-04-19 |
2020-12-29 | ₩100.00 | annually | 2021-04-20 |
2019-12-27 | ₩80.00 | annually | 2020-04-14 |
2018-12-27 | ₩80.00 | annually | 2019-04-23 |
2017-12-27 | ₩80.00 | annually | 2018-04-10 |
2016-12-28 | ₩80.00 | annually | |
2015-12-29 | ₩80.00 | annually | |
2014-12-29 | ₩80.00 | annually | |
2013-12-27 | ₩70.00 | annually | |
2012-12-27 | ₩60.00 | annually |
Kwang Dong Pharmaceutical Dividend per year
Kwang Dong Pharmaceutical Dividend growth
Kwang Dong Pharmaceutical Dividend Yield
Kwang Dong Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.79%. Interested in purchasing Kwang Dong Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Kwang Dong Pharmaceutical Financial Ratios
Kwang Dong Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Kwang Dong Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Kwang Dong Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Kwang Dong Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Kwang Dong Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Kwang Dong Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Kwang Dong Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Kwang Dong Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Kwang Dong Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Kwang Dong Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Kwang Dong Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Kwang Dong Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.